<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00989729</url>
  </required_header>
  <id_info>
    <org_study_id>EVAR-150-2009</org_study_id>
    <secondary_id>EudraCT number 2009-013441-28</secondary_id>
    <secondary_id>H-A-2009-043</secondary_id>
    <nct_id>NCT00989729</nct_id>
  </id_info>
  <brief_title>Preoperative Methylprednisolone in Endovascular Aortic Repair</brief_title>
  <acronym>POMEVAR</acronym>
  <official_title>Preoperative Methylprednisolone in Endovascular Aortic Repair - a Randomized Double Blind Placebo Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Louise de la Motte</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to attenuate the systemic inflammatory response after
      Endovascular repair of abdominal aortic aneurysms, by administration of a single preoperative
      dosage of Methylprednisolone.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Systemic inflammatory response syndrome - SIRS</measure>
    <time_frame>Within 5 postoperative days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of postoperative hospital stay</measure>
    <time_frame>Until discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin 6 plasma level</measure>
    <time_frame>Within 5 postoperative days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events related to Methylprednisolone</measure>
    <time_frame>Within 5 postoperative days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Abdominal Aortic Aneurysms</condition>
  <arm_group>
    <arm_group_label>Methylprednisolone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>75 patients will receive a single preoperative dosage of Methylprednisolone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physiological Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>75 patients will receive a single preoperative dosage of Physiological Saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylprednisolone</intervention_name>
    <description>A single preoperative dosage 30 mg/kg Methylprednisolone suspended in physiological saline (100 ml in total) given intravenously as a 30 minute infusion, 2 hours before surgery.</description>
    <arm_group_label>Methylprednisolone</arm_group_label>
    <other_name>Solu-Medrol, Pfizer.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Physiological Saline</intervention_name>
    <description>A single preoperative dosage 100 ml given intravenously as a 30 minute infusion, 2 hours before surgery</description>
    <arm_group_label>Physiological Saline</arm_group_label>
    <other_name>Physiological Saline 9 mg/ml, Fresenius Kabi</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective endovascular repair of an asymptomatic abdominal aortic aneurysm.

          -  Informed signed consent

        Exclusion Criteria:

          -  Positive HIV status, positive hepatitis B or C status

          -  Immunoinflammatory disease - except topically treated skin disease and respiratory
             disease.

          -  Glaucoma

          -  Gastric or duodenal ulcer

          -  Systemic fungal infection

          -  Immunosuppressive treatment

          -  Current treatment for cancer

          -  Allergy towards contents of Solu-Medrol

          -  Alcohol consumption: Men &gt; 21 drinks and women &gt; 14 drinks weekly

          -  Pregnancy

          -  Lack of informed signed consent

          -  Patients where follow up is planned at other location than Rigshospitalet.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Louise de la Motte, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Vascular Surgery, Rigshospitalet 3111</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <results_reference>
    <citation>de la Motte L, Kehlet H, Vogt K, Nielsen CH, Groenvall JB, Nielsen HB, Andersen A, Schroeder TV, LÃ¶nn L. Preoperative methylprednisolone enhances recovery after endovascular aortic repair: a randomized, double-blind, placebo-controlled clinical trial. Ann Surg. 2014 Sep;260(3):540-8; discussion 548-9. doi: 10.1097/SLA.0000000000000895.</citation>
    <PMID>25115430</PMID>
  </results_reference>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 2, 2009</study_first_submitted>
  <study_first_submitted_qc>October 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 5, 2009</study_first_posted>
  <last_update_submitted>November 12, 2014</last_update_submitted>
  <last_update_submitted_qc>November 12, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Louise de la Motte</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Endovascular Aortic Repair</keyword>
  <keyword>Methylprednisolone</keyword>
  <keyword>Systemic inflammatory response syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

